Group 1 - The core point of the news is that Purui Eye Hospital Group's stock price increased by 5.07% to 38.77 CNY per share, with a total market capitalization of 5.801 billion CNY as of the report date [1] - Purui Eye Hospital, established on March 23, 2006, and listed on July 5, 2022, provides comprehensive ophthalmic medical services, including diagnosis, treatment, and optical services [1] - The revenue composition of Purui Eye Hospital includes: refractive projects 49.36%, cataract projects 19.77%, comprehensive eye disease projects 16.65%, optical projects 13.03%, and other services 1.18% [1] Group 2 - From the perspective of major shareholders, Rongtong Fund's health industry flexible allocation mixed fund A/B (000727) reduced its holdings by 192,500 shares in the third quarter, now holding 2.4 million shares, accounting for 1.69% of the circulating shares [2] - The fund has achieved a return of 13.2% year-to-date, ranking 5439 out of 8219 in its category, and a return of 2.01% over the past year, ranking 7380 out of 8125 [2] - The fund manager, Wan Minyuan, has a tenure of 9 years and 79 days, with the fund's total asset size at 5.957 billion CNY and a best return of 139.91% during his tenure [3] Group 3 - The Rongtong health industry flexible allocation mixed fund A/B (000727) has Purui Eye Hospital as its eighth largest holding, with the stock accounting for 3.62% of the fund's net value [4] - The fund's floating profit from its holdings in Purui Eye Hospital is approximately 4.488 million CNY as of the report date [4]
普瑞眼科股价涨5.07%，融通基金旗下1只基金重仓，持有240万股浮盈赚取448.8万元